Director/PDMR Shareholding

RNS Number : 0416X

Omega Diagnostics Group PLC

16 December 2019

 

OMEGA DIAGNOSTICS GROUP PLC

("Omega" or the "Company" or the "Group")

Director / PDMR Shareholding

Omega Diagnostics (AIM: ODX), the medical diagnostics company focused on allergy, food intolerance and infectious disease, announces that Kieron Harbinson, Group Finance Director, has sold and bought back 4,554 Ordinary Shares in the Company. Mr Harbinson's ownership of shares in the Company therefore remains unchanged.

The sale of 4,554 Ordinary Shares was conducted at 11.2 pence per share on 11 December 2019 by Mr Harbinson's pension administrator, without his knowledge or consent. Mr Harbinson was notified of the sale on 13 December 2019 and immediately re-purchased the Ordinary Shares into his ISA, at a price of 13.49 pence per Ordinary Share.

Mr Harbinson's ownership of Ordinary Shares in the Company remains unchanged at 681,617 Ordinary Shares, representing 0.45 per cent. of the issued share capital of the Company.

The FCA notification, made in accordance with the requirements of the EU Market Abuse Regulation is appended below.

The information communicated in this announcement is inside information for the purposes of Article 7 of EU Regulation 596/2014.

Contacts: 

Omega Diagnostics Group PLC	Tel: [phone]
David Evans, Non-Executive Chairman Colin King, Chief Executive	www.omegadiagnostics.com
Kieron Harbinson, Group Finance Director	Mob: [phone]
finnCap Ltd	Tel: [phone]
Geoff Nash/Hannah Boros (Corporate Finance)
Camille Gochez (Corporate Broking)
Walbrook PR Limited	Tel: [phone] or [e-mail]
Paul McManus	Mob: [phone]
Lianne Cawthorne	Mob: [phone]

	Details of the person discharging managerial responsibilities/person closely associated
a)	Name:	Keiron Harbinson
	Reason for the notification
a)	Position/status:	Group Finance Director
b)	Initial notification/Amendment:	Initial Notification
	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name:	Omega Diagnostics Group Plc
b)	LEI:	2138007U9P4BTZTYIR92
	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument: Identification code:	Ordinary Shares of 0.5 pence each GB00B1VCP282
b)	Nature of the transaction:	Sale of Ordinary Shares
c)	Price(s) and volume(s):	Price(s) Volume(s) 11.2 pence 4,554
d)	Aggregated information: ·    Aggregated volume: ·    Price:	Single transaction as in 4 c) above Price(s) Volume(s) 11.2 pence 4,554
e)	Date of the transaction:	11 December 2019
f)	Place of the transaction:	LSE

	Details of the person discharging managerial responsibilities/person closely associated
a)	Name:	Keiron Harbinson
	Reason for the notification
a)	Position/status:	Group Finance Director
b)	Initial notification/Amendment:	Initial Notification
	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name:	Omega Diagnostics Group Plc
b)	LEI:	2138007U9P4BTZTYIR92
	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument: Identification code:	Ordinary Shares of 0.5 pence each GB00B1VCP282
b)	Nature of the transaction:	Purchase of Ordinary Shares
c)	Price(s) and volume(s):	Price(s) Volume(s) 13.49 pence 4,554
d)	Aggregated information: ·    Aggregated volume: ·    Price:	Single transaction as in 4 c) above Price(s) Volume(s) 13.49 pence 4,554
e)	Date of the transaction:	16 December 2019
f)	Place of the transaction:	LSE

 

END

 

 

DSHBUBDDCUBBGCL